Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Balsa

Showing results (241-250 of 246) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 246 results.
Arthritis & Rheumatology (Hoboken, N.J.)|September 26, 2018
Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association StudyRaquel López-Mejías, F David Carmona, Fernanda Genre, et al.
Scientific Reports|January 31, 2020
Influence of MUC5B gene on antisynthetase syndromeRaquel López-Mejías, Sara Remuzgo-Martínez, Fernanda Genre, et al.
Annals of the Rheumatic Diseases|February 18, 2014
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptidesL Bossini-Castillo, C de Kovel, H Kallberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association StudiesElena López-Isac, Jose-Ezequiel Martín, Shervin Assassi, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Pageof 25

Showing results (241-250 of 246) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 246 results.
Arthritis & Rheumatology (Hoboken, N.J.)|September 26, 2018
Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association StudyRaquel López-Mejías, F David Carmona, Fernanda Genre, et al.
Scientific Reports|January 31, 2020
Influence of MUC5B gene on antisynthetase syndromeRaquel López-Mejías, Sara Remuzgo-Martínez, Fernanda Genre, et al.
Annals of the Rheumatic Diseases|February 18, 2014
A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptidesL Bossini-Castillo, C de Kovel, H Kallberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association StudiesElena López-Isac, Jose-Ezequiel Martín, Shervin Assassi, et al.
Annals of the Rheumatic Diseases|January 24, 2020
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 updateJosef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, et al.
Annals of the Rheumatic Diseases|November 10, 2022
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, et al.
Pageof 25